Skip to main content

Table 1 Clinical characteristics of COPD patients, smokers and non-smokers

From: Cigarette smoke alters the ability of human dendritic cells to promote anti-Streptococcus pneumoniae Th17 response

Group

Nb

Sexe (M/F)

Age

Smoking (pack-year)

FEV1 %

PO2

BODE

Inhaled corticosteroid

COPD

9

8/1

57.8 ± 3.2

57 ± 5.9

57.8 ± 7.9

70.9 ± 2.3

2.4 ± 0.8

4

Smokers

13

10/3

42.6 ± 4.9

35.4 ± 4.6

93.6 ± 1.5

ND

ND

0

Non smokers

14

10/4

45.5 ± 5.7

0

95.3 ± 3.5

ND

ND

0

  1. FEV1%, percentage of the forced expiratory lung volume in the first second; PO2, blood partial pressure of oxygen; BODE: index combining Body mass index, airflow obstruction, dyspnea and exercise capacity (6-minute walk test). Results are expressed as mean ± SEM
  2. ND not determined